SPL
Click for more information
1.11% 9.1¢ starpharma holdings limited

The study was supported by Symbiomix. Dr. Schwebke is a...

  1. RELAYER
    380 Posts.
    lightbulb Created with Sketch. 2
    clock Created with Sketch.
    01/09/16
    08:59
    Post #: 18845535
    The study was supported by Symbiomix. Dr. Schwebke is a consultant for Symbiomix and receives funding from Alfa Wassermann and Starpharma, among others. Dr. Hillier is coprincipal investigator of the Microbicide Trials Network, sponsored by the National Institutes of Health
    SPL Price at posting: 70.0¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Hillcrest Partners with Ocean Batteries to Deploy ZVS Invert
right-arrow Created with Sketch.
RDN If you thought lithium was dead, think again. The Pilbara will be central to the next upswing
right-arrow Created with Sketch.
AL8 "What is the focus of AL8 and how is management going to attract shareholders to the registry?"
right-arrow Created with Sketch.
NEWS From the Floor: Gold questions answered...
right-arrow Created with Sketch.
BOT US FDA approves Botanix Pharma's excessive underarm sweat drug
right-arrow Created with Sketch.
NEWS From the Floor question: "Is lithium dead?"
right-arrow Created with Sketch.
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.1¢ 		Change
0.001(1.11%) 		Mkt cap ! $37.49M
Open High Low Value Volume
9.1¢ 9.3¢ 8.9¢ $196.0K 2.178M

Buyers (Bids)

No. Vol. Price($)
1 164414 9.1¢
 

Sellers (Offers)

Price($) Vol. No.
9.5¢ 15150 1
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.